Author:
Sekar Vasanthakumar,Vedhachalam Devarajan,VB ArunKumar,Sivaraman Sivananthan,Janakarajan Venkatakrishnan,Sethuraman Sai,Shiroor Sandeep G.,Geoffroy Jean-Marie M.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. PROGRAF Patient Information Leaflet. U.S. Food & Drug Administration website. https://www.fda.gov. Revised 11/22/2022.
2. Sommers CD, Pang ES, Ghasriani H, Berendt RT, Vilker VL, Keire DA, et al. Analyses of marketplace tacrolimus drug product quality: Bioactivity, NMR and LC-MS. J Pharm Biomed Anal. 2013;85:108–17.
3. Staatz CE, Tett SE. Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients. Clin Pharmacokinet. 2015;54:993–1025.
4. U.S. Food & Drug Administration: FDA. Drugs@FDA: FDA-approved drugs. In: US FDA. MD, FDA; 2023.
5. Bulusu MA, Baumann K, Stuetz A. Chemistry of the immunomodulatory macrolide ascomycin and related analogues. Prog Chem Org Nat Prod. 2011;94:59–126.